Soleno Therapeutics (SLNO) Profit After Tax (2016 - 2017)
Historic Profit After Tax for Soleno Therapeutics (SLNO) over the last 5 years, with Q4 2017 value amounting to -$4.7 million.
- Soleno Therapeutics' Profit After Tax fell 8150.06% to -$4.7 million in Q4 2017 from the same period last year, while for Dec 2017 it was -$15.4 million, marking a year-over-year decrease of 2751.54%. This contributed to the annual value of -$175.9 million for FY2024, which is 35116.45% down from last year.
- Per Soleno Therapeutics' latest filing, its Profit After Tax stood at -$4.7 million for Q4 2017, which was down 8150.06% from -$3.8 million recorded in Q3 2017.
- In the past 5 years, Soleno Therapeutics' Profit After Tax registered a high of $1.9 million during Q2 2015, and its lowest value of -$11.7 million during Q1 2015.
- In the last 5 years, Soleno Therapeutics' Profit After Tax had a median value of -$2.9 million in 2015 and averaged -$3.3 million.
- Data for Soleno Therapeutics' Profit After Tax shows a peak YoY increase of 16734.69% (in 2015) and a maximum YoY decrease of 129700.24% (in 2015) over the last 5 years.
- Quarter analysis of 5 years shows Soleno Therapeutics' Profit After Tax stood at -$974243.0 in 2013, then crashed by 640.95% to -$7.2 million in 2014, then soared by 60.59% to -$2.8 million in 2015, then grew by 8.13% to -$2.6 million in 2016, then tumbled by 81.5% to -$4.7 million in 2017.
- Its Profit After Tax was -$4.7 million in Q4 2017, compared to -$3.8 million in Q3 2017 and -$4.0 million in Q2 2017.